Source: International Congress 2017 – Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP)
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Niederman (New York, United States of America). Antibiotic treatment considerations beyond guidelines. International Congress 2017 – Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP)

Member's Comments

No comment yet.

Related content which might interest you: Treatment options and recommendations Source: Virtual Congress 2021 – ERS clinical practice guidelines on treatment of sarcoidosis Year: 2021 Treatment options and recommendations Source: Virtual Congress 2021 – ERS Clinical practice guidelines for managing children and adolescents with bronchiectasis Year: 2021 Treatment options and recommendations Source: International Congress 2019 – European guidelines for malignant pleural mesothelioma management in 2019 Year: 2019 Treatment options and recommendations Source: Virtual Congress 2021 – ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea Year: 2021 ERS guidelines: treatment options and recommendations Source: International Congress 2019 – Guidelines for long-term non-invasive ventilation in chronic obstructive pulmonary disease Year: 2019 Antibiotic prescribing in acute respiratory infections – are we following guidelines? Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006 Community acquired pneumonia guidelines: not only treatment indications Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis Year: 2004 CAP and HAP guidelines: treatment indications and more Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Antibiotic management and resistance Source: Eur Respir Monogr 2018; 81: 312-330 Year: 2018 Treatment guidelines for CAP and the role of macrolides Source: Annual Congress 2004 - Developments in the management of lower respiratory tract infections Year: 2004 Antibiotic stewardship Source: Annual Congress 2012 - Infection control of respiratory pathogens Year: 2012 The new ATS/ERS/IDSA/CDC guidelines for MDR-TB: rationale, methods and recommendations Source: International Congress 2019 – Managing drug-resistant tuberculosis: from new guidelines to clinical practice Year: 2019 Adaptation rate between COPD treatment in clinical practice and guidelines recommendations Source: Eur Respir J 2007; 30: Suppl. 51, 779s Year: 2007 Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice. Source: International Congress 2017 – COPD management Year: 2017 Impact of guidelines on HAP and VAP outcomes Source: Eur Respir Mon 2011; 53: 66-73 Year: 2011 A clinical and aetiological evaluation of community acquired pneumonia-are we following guidelines in prescribing antibiotics? Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009